MedPath

A clinical trial to study the effect of two drugs, Fentanyl and Buprenorphine as an adjuvant to Bupivacaine in spinal anaesthesia for Lower Segment Cesarean Sectio

Phase 3
Conditions
Health Condition 1: O80- Encounter for full-term uncomplicated delivery
Registration Number
CTRI/2021/07/034806
Lead Sponsor
Bharati Vidyapeeth Deemed to be University medical college and research center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA II

Exclusion Criteria

�ASA III/IV/V

�Patients with comorbidites during pregnancy- gestational diabetes mellitus, pregnancy induce hypertension, heart disease

�Contraindications of spinal anaesthesia- raised intracranial pressure, local infection, coagulation disorders

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
�post Operative regain of sensory block and motor block <br/ ><br>�post operative duration of first rescue analgesia demandTimepoint: Observation of motor and sensory block after spinal anaesthesia in lower segment caesarean section every 5 minutes upto 10 minutes then every 10 minutes upto end of surgery
Secondary Outcome Measures
NameTimeMethod
Hemodynamic stability after giving spinal anaesthesia in lower segment caesarean sectionTimepoint: Heart rate, systolic blood pressure, diastolic blood pressure, respiratory rate, oxygen saturation for every 5 min for 10 minutes then every 10 minutes upto end of surgery
© Copyright 2025. All Rights Reserved by MedPath